Skip to main content
Caplight Logo









CyteSi, Inc.

CyteSi, Inc.

Private
Menlo Park, CaliforniaHealthcare & Life Scienceshttps://cytesi.com

Last Round

Series A

Extension

May 3, 2024

Total Funding Raised

$12.4M

Company Overview

CyteSi, Inc. is a biotechnology company that develops digital microfluidics systems and Biological Processing Units (BPUs) to automate and digitize life science research workflows.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery, Workflow Automation, Semiconductors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

digital microfluidicslab-on-a-chipmicrofluidicslab automationBPUlaboratory automationbiological processing unitEWODelectrowetting-on-dielectricsoftware-defined labNGSnext-generation sequencingliquid handlingdrug discoverybiotech hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CyteSi, Inc. Comparables

Compare CyteSi, Inc. with similar companies based on industry and business-model similarity.

CyteSi, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Volta Labs
84%
Guangdong ACXEL Micro & Nano Tech Co., Ltd.
83%
INTEGRA Holding AG
82%

CyteSi, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMay 3, 2024
Series AJun 3, 2022

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2024

    Raised $5.5M in a Series A Extension round.

  • Jun 3, 2022

    $7M round completed.

CyteSi, Inc. Filings

Explore SEC and related filing metadata, where available.

CyteSi, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CyteSi, Inc.'s valuation, stock price, and market status.

Is CyteSi, Inc. a public or private company?

CyteSi, Inc. is a private company.

What is the current stock price of CyteSi, Inc.?

CyteSi, Inc. is a private company, so its shares have no public market price. Caplight tracks CyteSi, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CyteSi, Inc. worth (valuation)?

Valuation information for CyteSi, Inc. is not publicly available.

Can I buy CyteSi, Inc. stock?

CyteSi, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CyteSi, Inc.'s last funding round?

CyteSi, Inc.'s most recent funding round was Series A Extension on May 3, 2024.

Who are the main investors in CyteSi, Inc.?

Investor information for CyteSi, Inc. is not publicly disclosed.

Will CyteSi, Inc. IPO soon?

No public IPO plans have been announced for CyteSi, Inc..

How can I track CyteSi, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in CyteSi, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersMenlo Park, California
Year Founded2018
Last FundingMay 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?